Skip to main content
Clinical Trials/JPRN-jRCT1041230082
JPRN-jRCT1041230082
Recruiting
未知

Effect of topical treatment with a combination of basic fibroblast growth factor and heparin on skin graft donor site healing: a randomized controlled pilot study

Kohyama Keishi0 sites12 target enrollmentSeptember 27, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Kohyama Keishi
Enrollment
12
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 27, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kohyama Keishi

Eligibility Criteria

Inclusion Criteria

  • Underwent split\-thickness skin graft (STSG) harvesting from the thigh for reconstructive surgery
  • Aged 20 \>\= years who signed an informed consent form
  • Provide written consent for participation in this study from the individual or a legal representative

Exclusion Criteria

  • Showed bleeding tendencies
  • Deemed inappropriate by the principal investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials